Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene versus placebo and raloxifene for fracture reduction in postmenopausal osteoporosis
2006-002053-69Phase 3Completed
- Sponsor
- Wyeth
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bazedoxifene in osteoporosis (4 arms), sponsored by Wyeth. Primary endpoint: Incidence of new vertebral fractures. Started Mar 2008; status: completed.
02
Drugs
bazedoxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2006-002053-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002053-69.